Alexion Pharma (ALXN) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.28, $0.04 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $600.3 million versus the consensus estimate of $594.4 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Forgent Power Solutions jumps as Bernstein sees massive earnings upside
- Investing.com’s stocks of the week
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
